Global Hyperthermia Cancer Treatment Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2024 to 2032

Description

List of Tables

The global demand for Hyperthermia Cancer Treatment Market is presumed to reach the market size of nearly USD 330.98 Million by 2032 from USD 186.99 Million in 2023 with a CAGR of 6.55% under the study period 2024-2032.

Hyperthermia cancer treatment is thermotherapy in which cancer cells are damaged and killed using thermal energy. The body tissues are exposed to high temperatures of up to 113°F. By doing this, cancer cells may shrink tumors. The effectiveness of hyperthermia therapy is dependent on the temperature achieved during the treatment, length of treatment, and cell and tissue characteristics. Hyperthermia cancer treatment is carried out alone or in combination with chemotherapy and radiation therapy.

MARKET DYNAMICS

The global hyperthermia cancer treatment market is at its nascent stage. Mounting cancer burden worldwide and spurring research on its effectiveness is projected to propel the demand for hyperthermia cancer treatment. Cancer is the primary cause of death, accounting for nearly 10 million deaths in 2020. The cancer prevalence increases every day with rising alcohol & tobacco consumption, exposure to ultraviolet radiation, and an unhealthy lifestyle. Numerous clinical trials have examined hyperthermia in combination with chemotherapy and radiation therapy. The research has witnessed improved and progressive results favorable for commercial use, creating lucrative opportunities for the market. However, hyperthermia treatment may make some cancer cells more sensitive to radiation, cause skin discomfort or local pain, blisters, and sometimes burns, restraining market growth.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of Hyperthermia Cancer Treatment. The growth and trends of Hyperthermia Cancer Treatment industry provide a holistic approach to this study.

MARKET SEGMENTATION

This section of the Hyperthermia Cancer Treatment market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Device Type

Infrared Hyperthermia Devices
Ultrasound Hyperthermia Devices
Microwave Hyperthermia Devices
Others

By Treatment Method

Locoregional Method (External & Interstitial, Intraluminal or Endocavitary Methods, Continuous Hyperthermic Peritoneal Perfusion (CHPP), Deep Tissue & Regional Perfusion)
Whole-body

By Application

Breast Cancer
Liver Cancer
Soft Tissue Sarcoma
Head & Neck Tumors
Prostate Cancer
Others

By End User

Hospitals & Specialty Clinics
Ambulatory Surgical Centers
Others

REGIONAL ANALYSIS

This section covers the regional outlook, which accentuates current and future demand for the Hyperthermia Cancer Treatment market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the Hyperthermia Cancer Treatment market include Pyrexar Medical, Celsius42 GmbH, Hydrosun GmbH, Oncotherm Kft, Andromedic S.R.L., YamamotVinita Co. Ltd., Chongqing Haifu Medical Technology Co. Ltd., InnoMedicus Ltd., Gamida, RanD. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

Product Code: VMR11215080

1. PREFACE

1.1. Report Description
- 1.1.1 Objective
- 1.1.2 Target Audience
- 1.1.3 Unique Selling Proposition (USP) & offerings
1.2. Research Scope
1.3. Research Methodology
- 1.3.1 Market Research Process
- 1.3.2 Market Research Methodology

2. EXECUTIVE SUMMARY

2.1. Highlights of Market
2.2. Global Market Snapshot

3. HYPERTHERMIA CANCER TREATMENT - INDUSTRY ANALYSIS

3.1. Introduction - Market Dynamics
3.2. Market Drivers
3.3. Market Restraints
3.4. Opportunities
3.5. Industry Trends
3.6. Porter's Five Force Analysis
3.7. Market Attractiveness Analysis
- 3.7.1 Market Attractiveness Analysis By Device Type
- 3.7.2 Market Attractiveness Analysis By Treatment Method
- 3.7.3 Market Attractiveness Analysis By Application
- 3.7.4 Market Attractiveness Analysis By End User
- 3.7.5 Market Attractiveness Analysis By Region

4. VALUE CHAIN ANALYSIS

4.1. Value Chain Analysis
4.2. Raw Material Analysis
- 4.2.1 List of Raw Materials
- 4.2.2 Raw Material Manufactures List
- 4.2.3 Price Trend of Key Raw Materials
4.3. List of Potential Buyers
4.4. Marketing Channel
- 4.4.1 Direct Marketing
- 4.4.2 Indirect Marketing
- 4.4.3 Marketing Channel Development Trend

5. GLOBAL HYPERTHERMIA CANCER TREATMENT MARKET ANALYSIS BY DEVICE TYPE

5.1. Overview By Device Type
5.2. Historical and Forecast Data Analysis By Device Type
5.3. Infrared Hyperthermia Devices Historic and Forecast Sales By Regions
5.4. Ultrasound Hyperthermia Devices Historic and Forecast Sales By Regions
5.5. Microwave Hyperthermia Devices Historic and Forecast Sales By Regions
5.6. Others Historic and Forecast Sales By Regions

6. GLOBAL HYPERTHERMIA CANCER TREATMENT MARKET ANALYSIS BY TREATMENT METHOD

6.1. Overview By Treatment Method
6.2. Historical and Forecast Data Analysis By Treatment Method
6.3. Locoregional Method (External & Interstitial, Intraluminal or Endocavitary Methods, Continuous Hyperthermic Peritoneal Perfusion (CHPP), Deep Tissue & Regional Perfusion) Historic and Forecast Sales By Regions
6.4. Whole-body Historic and Forecast Sales By Regions

7. GLOBAL HYPERTHERMIA CANCER TREATMENT MARKET ANALYSIS BY APPLICATION

7.1. Overview By Application
7.2. Historical and Forecast Data Analysis By Application
7.3. Breast Cancer Historic and Forecast Sales By Regions
7.4. Liver Cancer Historic and Forecast Sales By Regions
7.5. Soft Tissue Sarcoma Historic and Forecast Sales By Regions
7.6. Head & Neck Tumors Historic and Forecast Sales By Regions
7.7. Prostate Cancer Historic and Forecast Sales By Regions
7.8. Others Historic and Forecast Sales By Regions

8. GLOBAL HYPERTHERMIA CANCER TREATMENT MARKET ANALYSIS BY END USER

8.1. Overview By End User
8.2. Historical and Forecast Data Analysis By End User
8.3. Hospitals & Specialty Clinics Historic and Forecast Sales By Regions
8.4. Ambulatory Surgical Centers Historic and Forecast Sales By Regions
8.5. Others Historic and Forecast Sales By Regions

9. GLOBAL HYPERTHERMIA CANCER TREATMENT MARKET ANALYSIS BY GEOGRAPHY

9.1. Regional Outlook
9.2. Introduction
9.3. North America Sales Analysis
- 9.3.1 Overview, Historic and Forecast Data Sales Analysis
- 9.3.2 North America By Segment Sales Analysis
- 9.3.3 North America By Country Sales Analysis
- 9.3.4 United States Sales Analysis
- 9.3.5 Canada Sales Analysis
- 9.3.6 Mexico Sales Analysis
9.4. Europe Sales Analysis
- 9.4.1 Overview, Historic and Forecast Data Sales Analysis
- 9.4.2 Europe By Segment Sales Analysis
- 9.4.3 Europe By Country Sales Analysis
- 9.4.4 United Kingdom Sales Analysis
- 9.4.5 France Sales Analysis
- 9.4.6 Germany Sales Analysis
- 9.4.7 Italy Sales Analysis
- 9.4.8 Russia Sales Analysis
- 9.4.9 Rest Of Europe Sales Analysis
9.5. Asia Pacific Sales Analysis
- 9.5.1 Overview, Historic and Forecast Data Sales Analysis
- 9.5.2 Asia Pacific By Segment Sales Analysis
- 9.5.3 Asia Pacific By Country Sales Analysis
- 9.5.4 China Sales Analysis
- 9.5.5 India Sales Analysis
- 9.5.6 Japan Sales Analysis
- 9.5.7 South Korea Sales Analysis
- 9.5.8 Australia Sales Analysis
- 9.5.9 South East Asia Sales Analysis
- 9.5.10 Rest Of Asia Pacific Sales Analysis
9.6. Latin America Sales Analysis
- 9.6.1 Overview, Historic and Forecast Data Sales Analysis
- 9.6.2 Latin America By Segment Sales Analysis
- 9.6.3 Latin America By Country Sales Analysis
- 9.6.4 Brazil Sales Analysis
- 9.6.5 Argentina Sales Analysis
- 9.6.6 Peru Sales Analysis
- 9.6.7 Chile Sales Analysis
- 9.6.8 Rest of Latin America Sales Analysis
9.7. Middle East & Africa Sales Analysis
- 9.7.1 Overview, Historic and Forecast Data Sales Analysis
- 9.7.2 Middle East & Africa By Segment Sales Analysis
- 9.7.3 Middle East & Africa By Country Sales Analysis
- 9.7.4 Saudi Arabia Sales Analysis
- 9.7.5 UAE Sales Analysis
- 9.7.6 Israel Sales Analysis
- 9.7.7 South Africa Sales Analysis
- 9.7.8 Rest Of Middle East And Africa Sales Analysis

10. COMPETITIVE LANDSCAPE OF THE HYPERTHERMIA CANCER TREATMENT COMPANIES

10.1. Hyperthermia Cancer Treatment Market Competition
10.2. Partnership/Collaboration/Agreement
10.3. Merger And Acquisitions
10.4. New Product Launch
10.5. Other Developments

11. COMPANY PROFILES OF HYPERTHERMIA CANCER TREATMENT INDUSTRY

11.1. Top Companies Market Share Analysis
11.2. Market Concentration Rate
11.3. Pyrexar Medical
- 11.3.1 Company Overview
- 11.3.2 Company Revenue
- 11.3.3 Products
- 11.3.4 Recent Developments
11.4. Celsius42 GmbH
- 11.4.1 Company Overview
- 11.4.2 Company Revenue
- 11.4.3 Products
- 11.4.4 Recent Developments
11.5. Hydrosun GmbH
- 11.5.1 Company Overview
- 11.5.2 Company Revenue
- 11.5.3 Products
- 11.5.4 Recent Developments
11.6. Oncotherm Kft
- 11.6.1 Company Overview
- 11.6.2 Company Revenue
- 11.6.3 Products
- 11.6.4 Recent Developments
11.7. Andromedic S.R.L.
- 11.7.1 Company Overview
- 11.7.2 Company Revenue
- 11.7.3 Products
- 11.7.4 Recent Developments
11.8. YamamotVinita Co. Ltd.
- 11.8.1 Company Overview
- 11.8.2 Company Revenue
- 11.8.3 Products
- 11.8.4 Recent Developments
11.9. Chongqing Haifu Medical Technology Co. Ltd.
- 11.9.1 Company Overview
- 11.9.2 Company Revenue
- 11.9.3 Products
- 11.9.4 Recent Developments
11.10. InnoMedicus Ltd.
- 11.10.1 Company Overview
- 11.10.2 Company Revenue
- 11.10.3 Products
- 11.10.4 Recent Developments
11.11. Gamida
- 11.11.1 Company Overview
- 11.11.2 Company Revenue
- 11.11.3 Products
- 11.11.4 Recent Developments
11.12. RanD
- 11.12.1 Company Overview
- 11.12.2 Company Revenue
- 11.12.3 Products
- 11.12.4 Recent Developments

Note - In company profiling, financial details and recent developments are subject to availability or might not be covered in the case of private companies